Kurt F. Somerville’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,555
Closed -$339K 113
2025
Q3
$339K Sell
3,555
-1,600
-31% -$147K 0.06% 89
2025
Q2
$449K Sell
5,155
-7,256
-58% -$615K 0.08% 73
2025
Q1
$1.12M Sell
12,411
-45,139
-78% -$4.04M 0.19% 53
2024
Q4
$4.6M Sell
57,550
-22,668
-28% -$1.96M 0.77% 33
2024
Q3
$7.22M Sell
80,218
-1,382
-2% -$116K 1.16% 29
2024
Q2
$6.42M Buy
81,600
+286
+0.4% +$23.4K 1.08% 27
2024
Q1
$7.09M Buy
81,314
+4,035
+5% +$344K 1.21% 27
2023
Q4
$6.37M Buy
77,279
+9,865
+15% +$752K 1.2% 28
2023
Q3
$5.28M Buy
67,414
+6,482
+11% +$543K 1.06% 30
2023
Q2
$5.37M Buy
60,932
+11,095
+22% +$955K 1.02% 30
2023
Q1
$4.02M Buy
49,837
+22,389
+82% +$1.82M 0.73% 34
2022
Q4
$2.13M Sell
27,448
-25,475
-48% -$2.06M 0.41% 41
2022
Q3
$4.27M Buy
52,923
+7,578
+17% +$681K 0.86% 35
2022
Q2
$4.07M Buy
45,345
+21,190
+88% +$2.15M 0.77% 37
2022
Q1
$2.68M Buy
+24,155
New +$2.55M 0.43% 43
2015
Q3
Sell
-3,917
Closed -$291K 132
2015
Q2
$291K Buy
3,917
+171
+5% +$13.1K 0.07% 102
2015
Q1
$292K Buy
3,746
+816
+28% +$61.8K 0.07% 103
2014
Q4
$212K Buy
+2,930
New +$204K 0.05% 124

Other funds holding MDT

Kurt F. Somerville's MDT Position: Q4 2025 in Review

Kurt F. Somerville sold out of Medtronic (MDT) in Q4 2025, closing a stake of 3,555 shares — an estimated $339K sold.

Kurt F. Somerville first reported a position in MDT in Q4 2014 and held it in 18 quarters. The position peaked at $7.22M in Q3 2024. 2,303 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • Kurt F. Somerville reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
  • Kurt F. Somerville sold 3,555 Medtronic shares in Q4 2025, an estimated $339K.
  • Kurt F. Somerville first reported a position in Medtronic in Q4 2014 and held it in 18 quarters.
  • Kurt F. Somerville's Medtronic position peaked at $7.22M in Q3 2024.
  • 2,303 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Kurt F. Somerville's 13F filing for Q4 2025, filed 17 Feb 2026.